BlackRock Investment Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $3.8M | Buy |
148,729
+14,065
| +10% | +$359K | ﹤0.01% | 1780 |
|
|
2016
Q3 | $4.87M | Buy |
134,664
+206
| +0.2% | +$7.45K | 0.01% | 1501 |
|
|
2016
Q2 | $4.57M | Buy |
134,458
+16,696
| +14% | +$567K | 0.01% | 1497 |
|
|
2016
Q1 | $3.11M | Buy |
117,762
+13,183
| +13% | +$348K | ﹤0.01% | 1697 |
|
|
2015
Q4 | $5.1M | Buy |
104,579
+255
| +0.2% | +$12.4K | 0.01% | 1373 |
|
|
2015
Q3 | $2.6M | Buy |
104,324
+161
| +0.2% | +$4.01K | ﹤0.01% | 1873 |
|
|
2015
Q2 | $3.3M | Buy |
104,163
+30,577
| +42% | +$968K | ﹤0.01% | 1829 |
|
|
2015
Q1 | $2.8M | Buy |
73,586
+2,483
| +3% | +$94.5K | ﹤0.01% | 1793 |
|
|
2014
Q4 | $2.77M | Buy |
71,103
+14,089
| +25% | +$549K | ﹤0.01% | 1787 |
|
|
2014
Q3 | $1.72M | Buy |
57,014
+192
| +0.3% | +$5.81K | ﹤0.01% | 2099 |
|
|
2014
Q2 | $1.93M | Buy |
56,822
+36,416
| +178% | +$1.24M | ﹤0.01% | 2085 |
|
|
2014
Q1 | $704K | Buy |
20,406
+3,537
| +21% | +$122K | ﹤0.01% | 2741 |
|
|
2013
Q4 | $668K | Buy |
+16,869
| New | +$668K | ﹤0.01% | 2775 |
|